Rory B. Riggs, Director at Intra-Cellular Therapies, Inc. (ITCI), sold 8,924 shares at $75.57 ($674K) on 2024-06-24, disclosed to the SEC on 2024-06-25.
Open-market sale of $674k ITCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $75.57 | 4,462 | $337K | 50.0% |
| 2 | $75.57 | 4,462 | $337K | 50.0% |
| Total | $75.57 avg | 8,924 | $674K | 100% |
| Filing → |
| CBUS | BUY | 2023-06-02 | $32K | — | Filing → |
| RPRX | SELL | 2023-05-22 | $57.4M | — | Filing → |
| RPRX | SELL | 2023-03-30 | $10.2M | — | Filing → |